Tela Bio Earnings Estimate

TELA Stock  USD 0.97  -0.05  -4.90%   

Tela Bio next estimated EPS is -0.176 for 30th of June 2026. The current analyst range runs from -0.22 to -0.14. The last reported EPS was 0.00 as of 31st of March 2026. Review consensus EPS, actual EPS, and quarterly surprise history below. For broader company context, return to Tela Bio overview.

Macro event markers
 
Covid
 
Interest Hikes
  
Tela Bio has a market cap of 45.66 million, an operating margin of -31.86% on a trailing twelve-month basis, compared to -44.0% in the last reported annual period, current ratio of 3.83. Sector concentration and correlation with existing positions affect diversification impact. Broader economic conditions can influence Tela Bio's company valuation - related indicators include signals in state.
The fundamentals of trading Tela Bio Stock are covered in our How to Buy Tela Bio walkthrough. This resource outlines the process for evaluating Tela Bio Stock from a trading perspective. It covers the mechanics of investing in Tela Bio from account funding through order execution.

Earnings History

Quarterly gross profit history for Tela Bio is shown below using reported financial data.

Tela Bio Quarterly Gross Profit

$13.76 million
Statistical evidence for mean reversion in Tela Bio's appears through its tendency to revert after extreme valuations. Under mean reversion theory, Tela Bio's price extremes are viewed as temporary dislocations that may self-correct. Mean reversion in Tela Bio's is often observed around historical valuation multiples. Historical data for Tela Bio shows that extreme valuations have tended to normalize over multi-year periods.
Sentiment
Range
LowSentimentHigh
0.050.938.16
Details
Intrinsic
Valuation
LowIntrinsicHigh
0.061.248.47
Details
Naive
Forecast
LowNextHigh
0.021.008.23
Details
Analyst
Consensus
LowTargetHigh
2.052.252.50
Details
Tela Bio is positioned within its peer group by benchmarking margins, returns, and multiples. This peer-relative view identifies where Tela Bio leads, trails, or tracks its competitive set. Benchmarking earnings quality and balance sheet strength against peers provides additional valuation context. Tela Bio's relative positioning within the peer group reflects its competitive dynamics as currently priced by the market.

Earnings per Share Projection vs Actual

This chart compares actual EPS with consensus estimates and the current high-low analyst range by reporting date.

Estimated Months Earnings per Share

This chart shows the estimate series used for upcoming reporting periods.

Quarterly Analyst Estimates and Surprise Metrics

The table below lists reported EPS, estimated EPS, and the reported surprise for each available quarter.

Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
null
nullnullnullnull
2026-03-19
2025-12-31-0.175-0.170.005
2025-11-13
2025-09-30-0.16-0.19-0.0318 
2025-08-11
2025-06-30-0.18-0.22-0.0422 
2025-05-07
2025-03-31-0.2075-0.25-0.042520 
2025-03-19
2024-12-31-0.222-0.23-0.008
2024-11-07
2024-09-30-0.4-0.42-0.02
2024-08-12
2024-06-30-0.47-0.51-0.04
2024-05-09
2024-03-31-0.5-0.230.2754 
2024-03-21
2023-12-31-0.43-0.53-0.123 
2023-11-09
2023-09-30-0.49-0.450.04
2023-08-09
2023-06-30-0.53-0.460.0713 
2023-05-11
2023-03-31-0.56-0.63-0.0712 
2023-03-21
2022-12-31-0.55-0.520.03
2022-11-09
2022-09-30-0.63-0.64-0.01
2022-08-10
2022-06-30-0.62-0.79-0.1727 
2022-05-10
2022-03-31-0.56-0.75-0.1933 
2022-03-21
2021-12-31-0.55-0.59-0.04
2021-11-10
2021-09-30-0.52-0.57-0.05
2021-08-11
2021-06-30-0.52-0.57-0.05
2021-05-13
2021-03-31-0.48-0.56-0.0816 
2021-03-24
2020-12-31-0.49-0.54-0.0510 
2020-11-11
2020-09-30-0.49-0.53-0.04
2020-08-12
2020-06-30-0.59-0.530.0610 
2020-05-12
2020-03-31-0.56-0.63-0.0712 
2020-03-27
2019-12-31-0.59-1.22-0.63106 
2019-12-18
2019-09-30-0.56-0.020.5496 
2019-08-28
2019-06-30-0.58-0.470.1118